EXHIBIT A: January 18, 2011 Schedule 13D
Total Page:16
File Type:pdf, Size:1020Kb
Case 2:12-cv-00340-SDW-MCA Document 29-1 Filed 06/01/12 Page 1 of 20 PageID: 274 EXHIBIT A: January 18, 2011 Schedule 13D sc13d http://www.sec.gov/Archives/edgar/data/821536/000095012311003325/... Case 2:12-cv-00340-SDW-MCA Document 29-1 Filed 06/01/12 Page 2 of 20 PageID: 275 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Under the Securities Exchange Act of 1934 (Name of Issuer) Common Shares, par value $0.10 per share (Title of Class of Securities) 422360305 (CUSIP Number) Kevin M. Royer Siemens Corporation 170 Wood Avenue South Iselin, NJ 08830 (732) 590-6806 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) January 7, 2011 (Date of event which requires filing of this statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. þ 2 of 20 8/10/2011 11:41 AM sc13d http://www.sec.gov/Archives/edgar/data/821536/000095012311003325/... Case 2:12-cv-00340-SDW-MCA Document 29-1 Filed 06/01/12 Page 3 of 20 PageID: 276 Table of Contents CUSIP No. 422360305 NAME OF REPORTING PERSONS Siemens Hearing Instruments, Inc. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) o Not Applicable SEC USE ONLY SOURCE OF FUNDS OO CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) o CITIZENSHIP OR PLACE OF ORGANIZATION Delaware SOLE VOTING POWER NUMBER OF 6,400,000 SHARES SHARED VOTING POWER BENEFICIALLY OWNED BY 0 EACH SOLE DISPOSITIVE POWER REPORTING PERSON 6,400,000 WITH: SHARED DISPOSITIVE POWER 0 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,400,000 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 14.1%* TYPE OF REPORTING PERSON CO 3 of 20 8/10/2011 11:41 AM sc13d http://www.sec.gov/Archives/edgar/data/821536/000095012311003325/... Case 2:12-cv-00340-SDW-MCA Document 29-1 Filed 06/01/12 Page 4 of 20 PageID: 277 * Based on an aggregate of 45,447,433 shares of Common Stock outstanding as of November 5, 2010 as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarterly period ended September 25, 2010, filed with the Securities and Exchange Commission on November 9, 2010. -2- 4 of 20 8/10/2011 11:41 AM sc13d http://www.sec.gov/Archives/edgar/data/821536/000095012311003325/... Case 2:12-cv-00340-SDW-MCA Document 29-1 Filed 06/01/12 Page 5 of 20 PageID: 278 Table of Contents CUSIP No. 422360305 NAME OF REPORTING PERSONS Siemens Aktiengesellschaft CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) o Not Applicable SEC USE ONLY SOURCE OF FUNDS OO CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) þ CITIZENSHIP OR PLACE OF ORGANIZATION Federal Republic of Germany SOLE VOTING POWER NUMBER OF 6,400,000 SHARES SHARED VOTING POWER BENEFICIALLY OWNED BY 0 EACH SOLE DISPOSITIVE POWER REPORTING PERSON 6,400,000 WITH: SHARED DISPOSITIVE POWER 0 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,400,000 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 14.1%* TYPE OF REPORTING PERSON CO 5 of 20 8/10/2011 11:41 AM sc13d http://www.sec.gov/Archives/edgar/data/821536/000095012311003325/... Case 2:12-cv-00340-SDW-MCA Document 29-1 Filed 06/01/12 Page 6 of 20 PageID: 279 * Based on an aggregate of 45,447,433 shares of Common Stock outstanding as of November 5, 2010 as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarterly period ended September 25, 2010, filed with the Securities and Exchange Commission on November 9, 2010. -3- 6 of 20 8/10/2011 11:41 AM sc13d http://www.sec.gov/Archives/edgar/data/821536/000095012311003325/... Case 2:12-cv-00340-SDW-MCA Document 29-1 Filed 06/01/12 Page 7 of 20 PageID: 280 TABLE OF CONTENTS Item 1. Securities and Issuer Item 2. Identity and Background Item 3. Source and amount of Funds and Other Consideration Item 4. Purpose of the Transaction Item 5. Interest in Securities of the Issuer Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer Item 7. Material To Be Filed as Exhibits SIGNATURE Exhibit 7.7 7 of 20 8/10/2011 11:41 AM sc13d http://www.sec.gov/Archives/edgar/data/821536/000095012311003325/... Case 2:12-cv-00340-SDW-MCA Document 29-1 Filed 06/01/12 Page 8 of 20 PageID: 281 Table of Contents Item 1. Securities and Issuer This Schedule 13D (this “Statement”) relates to the common stock, par value $0.10 per share (the “Common Stock”), of HearUSA, Inc., a Delaware corporation (the “Issuer”). The principal executive offices of the Issuer are located at 1250 Northpoint Parkway, West Palm Beach, Florida 33407. Item 2. Identity and Background This Statement is being filed jointly by the following persons (each, individually, a “Reporting Person” and collectively the “Reporting Persons”): (1) Siemens Hearing Instruments, Inc., a Delaware corporation (“Siemens Hearing Instruments”) and (2) Siemens Aktiengesellschaft, a stock corporation organized under the laws of the Federal Republic of Germany (“Siemens AG”). Siemens Hearing Instruments’ business address is 10 Constitution Avenue, Piscataway, New Jersey 08855. Siemens AG’s business address is Wittelsbacherplatz 2, D-80333 Munich, Germany. Siemens Hearing Instruments is an indirect, wholly owned subsidiary of Siemens AG. The principal business of Siemens Hearing Instruments is to manufacture, supply and sell hearing instruments. Siemens AG is a global powerhouse in electronics and electrical engineering, operating in the industry, energy and healthcare sectors. The name, business address, citizenship and present principal occupation or employment of each director and executive officer of Siemens Hearing Instruments and of each member of the Managing Board and Supervisory Board of Siemens AG are set forth in Annex I hereto and are incorporated herein by reference. Except as set forth in Item 4 (under the heading “Legal Proceedings” commencing on page 40) of Siemens AG’s Annual Report on Form 20-F for the fiscal year ended September 30, 2010 filed with the Securities and Exchange Commission on December 2, 2010 and incorporated herein by reference (the “Form 20-F”), during the last five years, none of the Reporting Persons nor, to the best of each Reporting Persons’ knowledge, any person named in Annex I has been (a) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (b) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which proceeding such Reporting Person or person is or was subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. The discussion under the heading “Legal Proceedings” in Item 4 of the Form 20-F is incorporated herein by reference. Item 3. Source and amount of Funds and Other Consideration Pursuant to a Stock Purchase Agreement dated December 23, 2008 (the “Stock Purchase Agreement”), $3,800,000 of outstanding trade debt payable by the Issuer to Siemens Hearing Instruments under an Amended and Restated Supply Agreement dated December 30, 2006, as amended by a Second Amendment to Credit Agreement and First Amendment to Investor Rights Agreement and Supply Agreement dated September 28, 2007 (the “2007 Amendments”) (as amended, the “Supply Agreement”) was converted into 6,400,000 shares of the Issuer’s Common Stock (the “Shares”) at a conversion price equal to $0.60 per Share. The Stock Purchase Agreement, the 2007 Amendments and the Supply Agreement are included in the exhibits to this Statement and are incorporated herein by reference. - 4 - 8 of 20 8/10/2011 11:41 AM sc13d http://www.sec.gov/Archives/edgar/data/821536/000095012311003325/... Case 2:12-cv-00340-SDW-MCA Document 29-1 Filed 06/01/12 Page 9 of 20 PageID: 282 Table of Contents Item 4. Purpose of the Transaction Prior to December 23, 2008, the Issuer and Siemens Hearing Instruments were parties to (i) the Supply Agreement, pursuant to which the Issuer agreed to purchase at least 90% of the hearing aids it purchases in the United States from Siemens Hearing Instruments and its affiliates, (ii) a Second Amended and Restated Credit Agreement dated December 30, 2006, as amended by a First Amendment to Credit Agreement dated as of June 27, 2007 and the 2007 Amendments (as amended, the “Credit Agreement”), pursuant to which Siemens Hearing Instruments extended to the Issuer a $50 million credit facility and the Issuer granted Siemens Hearing Instruments the right to convert a portion of the outstanding loan amounts into Common Stock at certain times and upon certain conditions, (iii) an Amended and Restated Security Agreement dated February 10, 2006, as amended by Amendment No. 2 to Amended and Restated Security Agreement dated December 23, 2008 (as amended, the “Security Agreement”), pursuant to which the Issuer granted Siemens Hearing Instruments a continuing security interest in substantially all of the Issuer’s assets to secure its obligations under the Credit Agreement, (iv) an Investor Rights Agreement dated December 30, 2006, as amended by the 2007 Amendments (as amended, the “Investor Rights Agreement”), pursuant to which the Issuer agreed to register for resale any shares of Common Stock issued to Siemens Hearing Instruments pursuant to the conversion provisions under the Credit Agreement, and granted Siemens Hearing Instruments a right of first refusal to purchase any equity securities that the Issuer proposes to issue in a capital raising transaction and a right of first refusal that may be exercised if the Issuer proposes to enter into a change of control transaction with, or primarily involving, a person which derives a material portion of its revenue from the research, development, manufacturing, marketing or sale of hearing aids.